COCP/delivering presentations to certain potential investors
Apr 3, 2018 20:31:12 GMT
icemandios and dc like this
Post by c2crusher on Apr 3, 2018 20:31:12 GMT
Item 7.01 Regulation FD Disclosure
Beginning on April 4, 2018, senior executives of Cocrystal Pharma, Inc. (the “Company”), will be delivering presentations to certain potential investors. A copy of the Company’s investor presentation is being furnished as Exhibit 99.1 hereto and is hereby incorporated by reference.
The information in this Current Report on Form 8-K (including exhibits hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities under such section, and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act.
Cocrystal Pharma Investor Presentation dated April 2018
ir.cocrystalpharma.com/all-sec-filings/content/0001493152-18-004683/ex99-1.htm
Crusher
Beginning on April 4, 2018, senior executives of Cocrystal Pharma, Inc. (the “Company”), will be delivering presentations to certain potential investors. A copy of the Company’s investor presentation is being furnished as Exhibit 99.1 hereto and is hereby incorporated by reference.
The information in this Current Report on Form 8-K (including exhibits hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities under such section, and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act.
Cocrystal Pharma Investor Presentation dated April 2018
ir.cocrystalpharma.com/all-sec-filings/content/0001493152-18-004683/ex99-1.htm
Crusher